Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Poe

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
JCI Insight|October 5, 2018
SYK inhibitor entospletinib prevents ocular and skin GVHD in miceJonathan C Poe, Wei Jia, Julie A Di Paolo, et al.
Cancer Research|January 8, 2014
A reevaluation of CD22 expression in human lung cancerLaurentiu M Pop, Stephen Barman, Chunli Shao, et al.
Blood Advances|December 19, 2023
Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functionsSonali J Bracken, Amy N Suthers, Rachel A DiCioccio, et al.
Blood|February 3, 2021
BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantationWei Jia, Jonathan C Poe, Hsuan Su, et al.
Blood|August 31, 2017
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHDJonathan C Poe, Wei Jia, Hsuan Su, et al.
Blood|April 9, 2015
Targeting Syk-activated B cells in murine and human chronic graft-versus-host diseaseRyan Flynn, Jessica L Allen, Leo Luznik, et al.
JCI Insight|May 2, 2023
Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHDJonathan C Poe, Jiyuan Fang, Dadong Zhang, et al.
Transplantation and Cellular Therapy|December 28, 2022
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host DiseaseChenyu Lin, Rachel A DiCioccio, Tarek Haykal, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
JCI Insight|October 5, 2018
SYK inhibitor entospletinib prevents ocular and skin GVHD in miceJonathan C Poe, Wei Jia, Julie A Di Paolo, et al.
Cancer Research|January 8, 2014
A reevaluation of CD22 expression in human lung cancerLaurentiu M Pop, Stephen Barman, Chunli Shao, et al.
Blood Advances|December 19, 2023
Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functionsSonali J Bracken, Amy N Suthers, Rachel A DiCioccio, et al.
Blood|February 3, 2021
BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantationWei Jia, Jonathan C Poe, Hsuan Su, et al.
Blood|August 31, 2017
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHDJonathan C Poe, Wei Jia, Hsuan Su, et al.
Blood|April 9, 2015
Targeting Syk-activated B cells in murine and human chronic graft-versus-host diseaseRyan Flynn, Jessica L Allen, Leo Luznik, et al.
JCI Insight|May 2, 2023
Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHDJonathan C Poe, Jiyuan Fang, Dadong Zhang, et al.
Transplantation and Cellular Therapy|December 28, 2022
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host DiseaseChenyu Lin, Rachel A DiCioccio, Tarek Haykal, et al.
Pageof 8